MINNEAPOLIS, MN, 4C Medical Technologies, announced that it has completed a $35.4 million Series C Preferred Stock financing.
4C Medical Technologies, Inc , a privately-held medical technology company focused on the development of minimally invasive therapies for structural heart disease.
Announced that it has completed a $35.4 million Series C Preferred Stock financing. The Series C round was led by MicroPort CardioFlow Medtech Corporation.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
